J.& J. Is Said to Be Near Deal to Buy Guidant
565121
Johnson & Johnson, the pharmaceutical and health care giant, is near a deal to buy Guidant, one of the nation's largest makers of devices to treat heart and circulatory illnesses.
584724
Johnson &amp; Johnson (JNJ), the drug and health care products company, is reportedly in advanced negotiations to buy Guidant (GDT), a leading maker of devices to treat heart and circulatory illnesses, for more than $24 billion.
16804
Johnson &amp; Johnson Chief Executive Officer William Weldon plans to use the $25 billion purchase of defibrillator maker Guidant Corp.
202527
Johnson &amp; Johnson has made a deal to buy Guidant Corp. a producer of medical equipment for patients with heart and circulatory illnesses, for $24 billion in stock and cash.
557571
A long-anticipated merger may soon come true.
200948
Johnson &amp; Johnson said Wednesday night that it would acquire Indianapolis-based medical device manufacturer Guidant Corp. for $25.4 billion.
430700
INDIANAPOLIS -- Johnson &amp; Johnson has sealed a deal to buy medical device maker Guidant for $25.4 billion. Under the terms of the agreement, each Guidant share will be exchanged for $30.40 in cash and $45.60 in Johnson &amp; Johnson stock.
497700
NEW YORK -- Johnson &amp; Johnson, the New Jersey-based drug and health care products company, is reportedly in advanced negotiations to buy Guidant Corp.
585649
Stocks looked to open slightly higher  on Tuesday, helped by weakening oil prices and news of a  possible merger between Johnson & Johnson JNJ.N and  cardiovascular device maker Guidant Corp. GDT.N.
91019
Johnson &amp; Johnson, the pharmaceutical and health care giant, has announced an agreement to buy Guidant, one of the largest US makers of devices to treat heart and circulatory illnesses, for $25.4 billion.
336179
LONDON: Johnson &amp; Johnson has agreed to acquire Guidant Corp for US$25.4bil, adding electrical devices for treating heart disease to a line-up of thousands of health products ranging from Band-Aids to cardiac stents.
5729
Health care products giant Johnson &amp; Johnson&#39;s $25.4 billion acquisition of Guidant Corp. could face a tough review from regulators because of their competition in the coronary stent market, analysts say.
249844
CHICAGO/PHILADELPHIA  - Health care and consumer  products maker Johnson & Johnson JNJ.N is in negotiations to  acquire medical-device maker Guidant Corp. GDT.N, sources  familiar with the situation said on Tuesday.
340033
Johnson & Johnson is in advanced negotiations to acquire Guidant, one of the nation's largest makers of devices to treat heart illnesses, for more than $24 billion.
312826
Johnson &amp; Johnson announced that it will acquire Guidant Corp., one of the world&#39;s top makers of cardiac devices, for $25.4 billion US.
670784
NEW YORK - US health titan Johnson and Johnson is in &quot;advanced negotiations&quot; for a 24-billion-dollar takeover of US heart device manufacturer Guidant, the New York Times said.
373656
Johnson &amp; Johnson said late Wednesday that it will buy Guidant Corp. for $23.9 billion in a cash-and-stock deal that had been rumored for weeks.